Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders?
- PMID: 15521854
- DOI: 10.1111/j.1365-2036.2004.02184.x
Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders?
Abstract
Functional dyspepsia and irritable bowel syndrome are currently considered to be two separate nosological entities. However, the overlap of symptoms and the evidence of a number of common pathophysiological characteristics suggest that functional dyspepsia and irritable bowel syndrome may be different presentations of the same disorder. In this review, we critically appraise points in common, as well as differences, in the epidemiology, pathophysiology and response to treatment of functional dyspepsia and irritable bowel syndrome. Population-based studies and large case series show that one- to two-thirds of subjects with irritable bowel syndrome have symptoms that overlap with functional dyspepsia. Symptom analyses have generally failed to support functional dyspepsia and irritable bowel syndrome as separate entities. An exaggerated motor response to meals, delayed gastric emptying and abnormal small bowel and colonic transit can all be found in subsets of functional dyspepsia and irritable bowel syndrome, and are not exclusive to either condition. Visceral hypersensitivity is a common feature to both entities and seems unlikely to be site or disease specific. There is good evidence for the post-infectious development of irritable bowel syndrome, and this may also apply in functional dyspepsia. Psychiatric comorbidities are similar in functional dyspepsia and irritable bowel syndrome. Several common drug classes (prokinetics, visceral analgesics, psychoactive agents) may similarly improve both functional dyspepsia and irritable bowel syndrome symptoms. The evidence available suggests that at least subsets of functional dyspepsia and irritable bowel syndrome represent different manifestations of a single entity. The identification of common pathophysiological targets for therapy should be pursued in future research.
Similar articles
-
Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study.Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1101-9. doi: 10.1097/01.meg.0000231755.42963.c6. Eur J Gastroenterol Hepatol. 2006. PMID: 16957517
-
Dyspepsia, irritable bowel syndrome, and constipation: review and what's new.Rev Gastroenterol Disord. 2001;1(1):2-17. Rev Gastroenterol Disord. 2001. PMID: 12120117 Review.
-
The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.BMC Gastroenterol. 2008 Sep 23;8:43. doi: 10.1186/1471-230X-8-43. BMC Gastroenterol. 2008. PMID: 18808723 Free PMC article.
-
Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis?Am J Gastroenterol. 1997 Jun;92(6):954-9. Am J Gastroenterol. 1997. PMID: 9177509
-
Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.Phytomedicine. 2006;13 Suppl 5:114-21. doi: 10.1016/j.phymed.2006.03.022. Epub 2006 Sep 15. Phytomedicine. 2006. PMID: 16978851 Review.
Cited by
-
Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.Eur J Clin Pharmacol. 2007 Jun;63(6):529-36. doi: 10.1007/s00228-007-0287-3. Epub 2007 Mar 20. Eur J Clin Pharmacol. 2007. PMID: 17468863 Clinical Trial.
-
Psychopathological features of irritable bowel syndrome patients with and without functional dyspepsia: a cross sectional study.BMC Gastroenterol. 2011 Aug 26;11:94. doi: 10.1186/1471-230X-11-94. BMC Gastroenterol. 2011. PMID: 21871075 Free PMC article.
-
Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.Indian J Gastroenterol. 2014 May;33(3):265-73. doi: 10.1007/s12664-014-0447-1. Epub 2014 Mar 26. Indian J Gastroenterol. 2014. PMID: 24664445
-
Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.Clin Drug Investig. 2011 Dec 1;31(12):865-75. doi: 10.1007/BF03256924. Clin Drug Investig. 2011. PMID: 22035464
-
Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review.World J Gastroenterol. 2017 Oct 7;23(37):6788-6801. doi: 10.3748/wjg.v23.i37.6788. World J Gastroenterol. 2017. PMID: 29085223 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical